These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8072970)

  • 21. Aseptic meningitis and intravenous immunoglobulin therapy.
    Scribner CL; Kapit RM; Phillips ET; Rickles NM
    Ann Intern Med; 1994 Aug; 121(4):305-6. PubMed ID: 8037414
    [No Abstract]   [Full Text] [Related]  

  • 22. Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation.
    Wright SE; Shaikh ZH; Castillo-Lugo JA; Tanriover B
    Transpl Infect Dis; 2008 Jul; 10(4):294-7. PubMed ID: 18086279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Idiopathic thrombopenic purpura, intravenous immunoglobulins and aseptic meningitis].
    Piguet C; Fontmarty S; Gilbert B; Vodoff MV; de Lumley L
    Arch Pediatr; 1999 Dec; 6(12):1350-1. PubMed ID: 10627912
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute aseptic meningitis secondary to intravenous immunoglobulin in a patient with Kawasaki syndrome.
    Boyce TG; Spearman P
    Pediatr Infect Dis J; 1998 Nov; 17(11):1054-6. PubMed ID: 9849996
    [No Abstract]   [Full Text] [Related]  

  • 25. Incidence and natural history of intravenous immunoglobulin-induced aseptic meningitis: a retrospective review at a single tertiary care center.
    Bharath V; Eckert K; Kang M; Chin-Yee IH; Hsia CC
    Transfusion; 2015 Nov; 55(11):2597-605. PubMed ID: 26095012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intravenous immunoglobulins and aseptic meningitis].
    Mselati JC; Carlier JC; Routon MC; Noui Mehidi F; de Gennes C
    Arch Fr Pediatr; 1992 Mar; 49(3):216. PubMed ID: 1610283
    [No Abstract]   [Full Text] [Related]  

  • 27. Human intravenous immunoglobulin-induced aseptic meningitis: a case report.
    Chaabane A; Hamzaoui A; Aouam K; Klai R; Fredj NB; Boughattas NA; Mahjoub S
    J Clin Pharmacol; 2012 Feb; 52(2):279-81. PubMed ID: 21257801
    [No Abstract]   [Full Text] [Related]  

  • 28. [Aseptic meningitis following treatment with immunoglobulins: physiopathological and prognostic value of screening].
    Oddou S; Molinier S; Coso D; Boulet JM; Gastaut JA; Bouabdallah R
    Presse Med; 1995 May; 24(19):916. PubMed ID: 7638138
    [No Abstract]   [Full Text] [Related]  

  • 29. Repeated, severe headache in a lung transplant patient: a case report.
    Veranneman N; Van Raemdonck D; Dupont L; Verleden G
    Acta Clin Belg; 2010; 65(4):269-70. PubMed ID: 20954467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment with intravenous immunoglobulin in neurological diseases. A descriptive study of effects seen from the patient's and health services' perspectives].
    Wintzell A; Eriksson T; Lundgren A; Petersson J
    Lakartidningen; 2008 May 21-27; 105(21):1571-5. PubMed ID: 18574994
    [No Abstract]   [Full Text] [Related]  

  • 31. A new subset of common variable immune deficiency characterized by reduced C1 esterase inhibitor levels.
    Melamed IR; Heffron M; McGee S; Ulltate Sanz L; Testori A
    Ann Allergy Asthma Immunol; 2015 Jul; 115(1):83-4. PubMed ID: 26123426
    [No Abstract]   [Full Text] [Related]  

  • 32. Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.
    Wittstock M; Zettl UK
    J Neurol; 2006 Sep; 253 Suppl 5():V75-9. PubMed ID: 16998759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug induced aseptic meningitis caused by intravenous immunoglobulin therapy.
    Mullane D; Williams L; Merwick A; Tobin WO; McGuigan C
    Ir Med J; 2012 Jun; 105(6):182-3. PubMed ID: 22973657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of recurrent aseptic meningitis caused by high-dose intravenous gammaglobulin therapy for chronic inflammatory demyelinating polyneuropathy].
    Kato T; Suzuki E; Sone M; Yoshida E; Hirayama M
    Rinsho Shinkeigaku; 2001 Nov; 41(11):797-800. PubMed ID: 12080612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Side-effects of intravenous immune globulins.
    Duhem C; Dicato MA; Ries F
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):79-83. PubMed ID: 8033440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recalcitrant pemphigus vulgaris: aseptic meningitis associated with intravenous immunoglobulin therapy and successful treatment with rituximab.
    Ventura F; Rocha J; Fernandes JC; Machado A; Brito C
    Int J Dermatol; 2013 Apr; 52(4):501-2. PubMed ID: 23451774
    [No Abstract]   [Full Text] [Related]  

  • 37. [Adverse effects of intravenous human polyvalent immunoglobulins].
    Chapuis C; Guy N; Besson G
    Rev Neurol (Paris); 2008 Sep; 164 Spec No 3():F203-10. PubMed ID: 18992580
    [No Abstract]   [Full Text] [Related]  

  • 38. Intravenous immunoglobulins in neurological diseases.
    Zettl UK; Mix E
    J Neurol; 2006 Sep; 253 Suppl 5():V1. PubMed ID: 16998748
    [No Abstract]   [Full Text] [Related]  

  • 39. Multiple treatment cycles of high-dose intravenous immunoglobulin for chronic spontaneous urticaria.
    Hrabak T; Calabria CW
    Ann Allergy Asthma Immunol; 2010 Sep; 105(3):245; author reply 245-6. PubMed ID: 20800796
    [No Abstract]   [Full Text] [Related]  

  • 40. [Infectious mononucleosis associated with aseptic meningitis and segmental sensory disturbance].
    Kakigi R; Kuroda Y; Shibasaki H
    Rinsho Shinkeigaku; 1984 Nov; 24(11):1117-20. PubMed ID: 6097388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.